UHN Joins the Phase II Trial of LSALT Peptide Targeting Card

UHN Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

UHN Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Turkey , Canada , United States , Toronto , Ontario , Canadian , Richard Muruve , Princess Margaret Cancer Centre , University Health Network , Regulation Services Provider , Toronto Rehabilitation Institute , Arch Biopartners Inc , Department Of Anesthesia , Park Healthcare Centre , Michener Institute Of Education , Venture Exchange , Targeting Cardiac Surgery Associated Acute Kidney , Biopartners Inc , Anesthesia Clinical Trials Unit , Pain Management , Toronto General , Kidney Disease , Improving Global Outcomes , Placebo Controlled Study , Acute Kidney Injury , Patients Undergoing On Pump Cardiac , Surgery Associated Acute Kidney Injury , Science Advances , National Research Council , Canada Industrial Research Assistance Program , Cardiac Surgery Associated Acute Kidney Injury , Toronto General Hospital , Toronto Western Hospital , Michener Institute , West Park Healthcare , Arch Biopartner , Canadian Securities Administrator System , Electronic Document Analysis , Chief Science , Chief Executive Officer , Arch Biopartners ,